Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients

Transplant International

Volumn 13, Issue 3, 2000, Pages 187-193

  Böhmig, Georg A ^a   Säemann, Marcus D ^b   Bergmann, Michael ^a   Watschinger, Bruno ^a   Regele, Heinz ^a   Windhager, Thomas ^a   Mühlbacher, Ferdinand ^a   Hörl, Walter H ^a   Zlabinger, G J ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Donor antigen specific reactivity; Immunologic monitoring; Mixed lymphocyte culture (MLC); Rejection; Transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; DEXAMETHASONE; KIDNEY ANTIGEN; MONOCLONAL ANTIBODY; ODULIMOMAB; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNITY; ANTIGEN SPECIFICITY; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; UREMIA;

ADULT; ANTIBODY SPECIFICITY; CADAVER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; ISOANTIGENS; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; SPLEEN; T-LYMPHOCYTES;

EID: 0033822916     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050685     Document Type: Article

References (26)

1. Specific tolerance in human kidney allograft recipients
2. Microchimerism linked to cytotoxic T-lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient
3. Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens in the mixed leukocyte reaction (MLR)
4. The use of cyclosporine in living-related renal transplantation: Donor-specific hyporesponsiveness and steroid withdrawal
5. Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR
6. Cell-mediated lympholysis studies in renal allograft recipients
7. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations
8. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1
9. Withdrawal of immunosuppressive drugs after renal transplantation - A world survey
10. T-cell function in chronic renal failure and dialysis
11. Ten-year follow-up of mixed lymphocyte reaction-hyporesponsive living related cyclosporine monotherapy-treated renal allograft recipients
12. Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders
13. A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipients
14. Long-term survivors of kidney transplantation, mortality, rehabilitation, and immunologic reactivities
15. Weaning of immunosuppression in long-term recipients of living related renal transplants: A preliminary study
16. Weaning of immunosuppression in liver transplant recipients
17. Posttransplant donor antigen-specific hyporeactivity in human transplantation
18. Evidence that improved late renal transplant outcome correlates with the development of in-vitro donor antigen-specific hyporeactivity
19. Development of specific nonreactivity in human cadaveric renal allograft recipients
20. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
21. Long term (25-year) survival after renal homotransplantation - The world experience
22. Intramolecular and intermolecular spreading during the course of organ allograft rejection
23. Immunological monitoring of long-surviving renal transplant recipients
24. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
25. Cell-mediated immune responses in renal transplant recipients treated with cyclosporin and prednisolone with or without azathioprine
26. Immune status of recipients following bone-marrow augmented solid organ transplantation